Market Overview

Recent Stories

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 27, 2015:

Solvay to Acquire Cytec for $75.25/Share in Cash

The Deal:

Escalade Sports, a wholly owned subsidiary of Escalade, Inc.

Novogen Limited (NASDAQ: NVGN) today confirmed it is committed to progressing its ground-breaking technology platforms to Phase 1 clinical trials as soon as practicable and to ensure the Company delivers the best value for shareholders.

Acting Chief Executive Officer, Iain Ross, said the Company currently had an extensive program of activities under

Unilife Corporation (NASDAQ: UNIS) today announced the implementation of a multifaceted financing strategy that provides the Company with flexibility and control to support its continued business growth.

Cara Therapeutics, Inc. (Nasdaq: CARA) today announced the pricing of its underwritten public offering of 3,763,440 shares of its common stock at a public offering price of $18.60 per share.

Facebook Inc (NASDAQ: FB) reported a second quarter EPS of $0.50 (vs. the Street estimate of $0.47) and sales of $4.04 billion (vs. $3.98 billion). MAUs rose to 1.49 billion, but investors were unimpressed. The stock initially fell more than 7 percent in after hours trading. As of 5:24 p.m.